These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7510452)

  • 1. Effect of calcium antagonists on RNA synthesis of NIH 3T3 cells.
    Andrawis NS; Abernethy DR
    Am J Med Sci; 1993 Sep; 306(3):137-40. PubMed ID: 7510452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse.
    Taylor JM; Simpson RU
    Cancer Res; 1992 May; 52(9):2413-8. PubMed ID: 1533173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of various L-type and T-type calcium antagonists on electrically generated, potassium-induced and carbachol-induced contractions of porcine detrusor muscle.
    Badawi JK; Li H; Langbein S; Kamp S; Guzman S; Bross S
    J Comp Physiol B; 2006 Jun; 176(5):429-39. PubMed ID: 16425017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and calmodulin: effect of verapamil, nifedipine and diltiazem.
    Daly MJ; Perry S; Nayler WG
    Eur J Pharmacol; 1983 May; 90(1):103-8. PubMed ID: 6307716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
    Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
    Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I mediates the stimulatory effect of high calcium concentration on osteoblastic cell proliferation.
    Sugimoto T; Kanatani M; Kano J; Kobayashi T; Yamaguchi T; Fukase M; Chihara K
    Am J Physiol; 1994 May; 266(5 Pt 1):E709-16. PubMed ID: 8203509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium antagonists on insulin-mediated glucose metabolism in skeletal muscle.
    Foot EA; Leighton B
    Diabetes; 1994 Jan; 43(1):73-9. PubMed ID: 8262320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of calcium channel blockers on duodenal calcium transport in vivo.
    Fox J; Green DT
    Eur J Pharmacol; 1986 Sep; 129(1-2):159-64. PubMed ID: 3770073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quin2 microfluorometry and effects of verapamil and diltiazem on calcium release from rat aorta smooth muscle cells in primary culture.
    Kanaide H; Kobayashi S; Nishimura J; Hasegawa M; Shogakiuchi Y; Matsumoto T; Nakamura M
    Circ Res; 1988 Jul; 63(1):16-26. PubMed ID: 3383374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of calcium-antagonists on the smooth vascular muscles].
    Ferrari R; Cargnoni A; Rodella A; Ciampalini G; Raddino R
    Cardiologia; 1985 May; 30(5):347-56. PubMed ID: 2421900
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of oxidant production by diltiazem, nifedipine and verapamil in human neutrophils.
    Feng YH; Hart G
    Clin Sci (Lond); 1996 Oct; 91(4):459-66. PubMed ID: 8983871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists: a new class of drugs.
    Nayler WG; Horowitz JD
    Pharmacol Ther; 1983; 20(2):203-62. PubMed ID: 6310649
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of organic Ca2+-antagonists on membrane characteristics of nodose ganglion cells in the rabbit.
    Ito H; Sakanashi M; Kawamura T; Nishi K
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):53-63. PubMed ID: 6497510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum.
    Paydar MJ; Pousti A; Farsam H; Amanlou M; Mehr SE; Dehpour AR
    Can J Physiol Pharmacol; 2005 Nov; 83(11):967-75. PubMed ID: 16391705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
    Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
    Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.